Xylem (XYL) Revenue — Quarter Ended Mar 31, 2025
Revenue declined compared to the immediately preceding quarter but rose relative to the same quarter one year earlier. The sequential decrease contrasts with the prior year's growth trend for this period.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue declined compared to the immediately preceding quarter but rose relative to the same quarter one year earlier. The sequential decrease contrasts with the prior year's growth trend for this period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.1B
Revenue reported for this quarter.
Quarter-over-quarter
-8.3%
Change from the immediately preceding quarter.
Year-over-year
+1.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$8.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $2.2B | +26.0% |
| Sep 30, 2024 | $2.1B | +1.3% |
| Dec 31, 2024 | $2.3B | +6.5% |
| Mar 31, 2025 | $2.1B | +1.8% |
Revenue performance
The reported revenue direction is downward from the prior quarter, while it is upward from the same quarter a year ago.
Quarterly comparison
Compared with the immediately preceding quarter, revenue decreased; versus the same quarter one year earlier, revenue increased.
What to watch
The sequential decline in revenue follows a period of consecutive quarter-over-quarter increases.